Secondary Prevention Education After Acute Myocardial Infarction

Anxiety Clinical Trial

Official title:

The Effect of Secondary Prevention Education Given to Individuals After Acute Myocardial Infarction on Physiological Parameters, Anxiety and Quality of Life

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04769219
• Other study ID #: AIBU-KYB-AYN-02
• Status: Completed
• Phase: N/A
• Start date: March 1, 2020
• Est. completion date: August 31, 2021

Study information

• Verified date: December 2023
• Source: Abant Izzet Baysal University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.

Description:

The aim of this study is to examine the effect of secondary prevention education given to individuals after acute myocardial infarction on physiological parameters, anxiety and quality of life.The population of the study will be the individuals hospitalized with the diagnosis of acute myocardial infarction in the Coronary Intensive Care Unit of Abant Izzet Baysal University Izzet Baysal Training and Research Hospital. The study will be conducted in a randomized controlled manner with two groups, 43 in the control group and 43 in the secondary prevention education group. CAG (Coronary Angiography) Procedure Training Form, Patient Identification Form, Physiological Parameters Form and Visual Analogue Scale, Spielberg State and Trait Anxiety Scale and Myocardial Infarction Dimensional Assessment Scale will be used to collect data. The data will be collected by face to face interview technique. For descriptive statistics, mean and standard deviation or median and minimum-maximum values for numerical variables, number and percentage values for categorical variables will be given. The Kolmogorov-Smirnov test (p <0.05), skewness and kurtosis coefficients (should be ± 1) and X ̅ / SS <4 inequalities will be examined at the same time, and the weight in which group will be preferred.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 86
• Est. completion date: August 31, 2021
• Est. primary completion date: March 1, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• First time AMI and inpatient treatment in the coronary intensive care unit,
• Not having received training after AMI *
• Being 18 years or older,
• Speak Turkish,
• No problem in verbal communication,
• Absence of hearing loss,
• Not being diagnosed with a psychiatric illness,
• Being conscious,
• Being volunteer to participate in the study,
• Routine check of cholesterol, HDL, LDL, triglyceride results at the beginning of the study and at 6 months. Exclusion Criteria: Not having had AMI for the first time
• Having received training after AMI
• Not willing to participate in the study,
• Cannot speak Turkish,
• Problems in verbal communication,
• Having hearing loss,
• Having a diagnosis of psychiatric illness,
• Unconsciousness.
• Cholesterol, HDL, LDL, triglyceride results were not routinely checked at the start and 6 months of the study.

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Education
• Infarction
• Myocardial Infarction
• Myocardial Infarction, Acute
• Quality of Life

Intervention

Other:
• Secondary prevention training
Secondary prevention training will be given after acute myocardial infarction

Locations

Country	Name	City	State
Turkey	Abant Izzet Baysal University	Merkez	Bolu

Sponsors (1)

Lead Sponsor	Collaborator
Abant Izzet Baysal University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	means of blood pressure (mmHg)	In the study, a digital sphygmomanometer, which has been calibrated in comparison with the mercury sphygmomanometer, is used in order to prevent individual differences in the measurement of blood pressure. For accurate results, the sphygmomanometer sleeve is sized for adult individuals (width = about 20 cm, length = about 40 cm). In order for the blood pressure not to be affected by the conditions during the measurement, it is taken into account that the individual did not drink tea or coffee, take caffeine, and preferably did not eat during the 30 minutes prior to measurement.	six months
Other	means of total cholesterol (mg/dl)	The values measured during routine blood checks will be taken for cholesterol values in this study.	six months
Other	means of HDL cholesterol (mg/dl)	The values measured during routine blood checks will be taken for cholesterol values in this study.	six months
Other	means of LDL cholesterol (mg/dl)	The values measured during routine blood checks will be taken for cholesterol values in this study.	six months
Other	means of triglyceride (mg/dl)	The values measured during routine blood checks will be taken for cholesterol values in this study.	six months
Primary	means of subjective anxiety scores	Spielberg State- Trait Anxiety Scale. The total score between 0-19 obtained from the state anxiety scale shows that there is no anxiety, the total score between 20-39 indicates mild, the average score between 40-59 indicates moderate, and the total score between 60-79 indicates severe anxiety, and over 60 points are needed for professional help. The scores obtained from the trait anxiety scale vary between 20 and 80. A high score means a high and a low level means anxiety	six months
Primary	means of subjective quality of life scores	It consists of 35 items and the quality of life is based on physical activity (12 items), insecurity (9 items), emotional response (4 items), addiction (3 items), diet (3 items), concerns about medication (2 items), Each sub-dimension of MIDAS, which measures seven domains as (2 items), is scored between 0-100. High scores indicate poor health.	six months
Secondary	means of subjective pain score	visual analog scale. It consists of a straight line with endpoints that define end limits such as "no pain" and "pain as bad as possible". The patient is asked to mark the level of pain on the line between the two endpoints.	six months